Double-Chin Drug Wins FDA Advisors' Backing

March 10, 2015 3:04 PM

17 0

Double-Chin Drug Wins FDA Advisors' Backing

With a 17-0 vote on Monday, the FDA's Dermatologic and Ophthalmic Drugs Advisory Committee recommended approval for an injectable drug to reduce submental fat, better known as double chin.

Deoxycholic acid (DCA) injection was "proposed for the improvement in the appearance of moderate-to-severe convexity or fullness associated with submental fat in adults." If it wins final FDA approval, deoxycholic acid will be the first medical treatment for excess chin fat.

Also read: Wendy Williams is the latest celebrity with Graves’ disease, which affects the body on the inside and out

Read more

To category page